Prodrug for tumor therapy
The world market for cancer diagnosis is estimated to be 3.5 billion dollars for 2010. Scientists at the University of Goettingen identified a new diagnostic tumor marker, which shows a general recognition of almost all cancers, an early detection of tumors and a very close causative link to cancer development. Thus, in the nearby future, this marker could also be used as a target for cancer therapy, as seen in first proof of principle experiments. The use in diagnostics of this new tumor marker would be ideal for first line of regular screening and for monitoring of a cancer therapy.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
